Core Viewpoint - The document outlines the behavior norms for the controlling shareholders and actual controllers of Celis Medical Technology Group Co., Ltd., aiming to enhance corporate governance, protect the rights of the company and its shareholders, and ensure compliance with relevant laws and regulations [2]. Group 1: General Principles - The norms are established to improve the corporate governance structure and regulate the actions of controlling shareholders and actual controllers [2]. - Controlling shareholders and actual controllers must adhere to the principles of honesty and credit, exercising shareholder rights and fulfilling obligations in accordance with laws and regulations [2]. - They are required to maintain the company's independence and not abuse their control to harm the interests of the company and other shareholders [2][3]. Group 2: Corporate Governance - Controlling shareholders and actual controllers must ensure the integrity of company assets and maintain independence in personnel, finance, organization, and business operations [3][4]. - They are prohibited from affecting the company's asset integrity through unfair practices, such as sharing production systems or using company assets without proper compensation [3][4]. - The independence of company personnel must be maintained, and controlling shareholders cannot influence personnel decisions outside of their legal rights [5][6]. Group 3: Financial Independence - Controlling shareholders and actual controllers must not use company funds for non-operational purposes or require the company to provide illegal guarantees [5][6]. - They are prohibited from sharing financial accounts or systems that could compromise the company's financial independence [5][6]. Group 4: Information Disclosure - Controlling shareholders and actual controllers must fulfill their information disclosure obligations accurately and completely, avoiding any false statements or omissions [9][10]. - They are required to establish clear procedures for reporting significant undisclosed information and maintain confidentiality regarding insider information [10][11]. Group 5: Share Trading and Control Transfer - Controlling shareholders must comply with legal regulations when trading shares and report any significant changes in shareholding promptly [11][12]. - They are required to ensure that any transfer of control is fair and does not harm the interests of the company or other shareholders [12][15]. Group 6: Other Provisions - Controlling shareholders and actual controllers must not engage in actions that could directly or indirectly infringe upon the company's assets or interests [29][30]. - They are responsible for ensuring that their commitments are enforceable and must provide guarantees for commitments with significant performance risks [31][32].
塞力医疗: 控股股东、实际控制人行为规范(2025年8月)